Financhill
Back

Defiance Nasdaq 100 Income Target ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison

Sell
16

QQQT
Defiance Nasdaq 100 Income Target ETF

Last Price:
$17.96
Seasonality Move:
-13.24%
Buy
60

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$784.09
Seasonality Move:
12.13%
Sell
16
Defiance Nasdaq 100 Income Target ETF (QQQT) is a Sell

Is Defiance Nasdaq 100 Income Target ETF a Buy, Sell or Hold?

  • The current Defiance Nasdaq 100 Income Target ETF [QQQT] share price is $17.96. The Score for QQQT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • QQQT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QQQT Stock Price Chart

What is Defiance Nasdaq 100 Income Target ETF's stock price today?

  • The Defiance Nasdaq 100 Income Target ETF share price today is $17.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals, Inc.'s stock price today?

  • The Regeneron Pharmaceuticals, Inc. share price today is $783.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

QQQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.39 Buy
Relative Strength Index (14 RSI): 51.16 Buy
Chaikin Money Flow: 26513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.61 - 18.11) Buy
Bollinger Bands (100): (17.82 - 18.5) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 204.17 Buy
Relative Strength Index (14 RSI): 67.2 Buy
Chaikin Money Flow: -261329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (720.67 - 774.53) Buy
Bollinger Bands (100): (555.56 - 709.04) Buy

QQQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.7 Buy
20-day SMA: 17.93 Buy
50-day SMA: 18.14 Sell
200-day SMA: 17.64 Buy
8-day EMA: 12.71 Buy
20-day EMA: 6.98 Buy
50-day EMA: 3.21 Buy
200-day EMA: 0.86 Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 764.21 Buy
20-day SMA: 747.28 Buy
50-day SMA: 691.09 Buy
200-day SMA: 601.8 Buy
8-day EMA: 603.24 Buy
20-day EMA: 348.3 Buy
50-day EMA: 164.33 Buy
200-day EMA: 44.8 Buy

Defiance Nasdaq 100 Income Target ETF Earnings Growth & QQQT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.

Defiance Nasdaq 100 Income Target ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):